The Food and Drug Administration has approved bemotrizinol, a UV light filter that has been a staple in sunscreens across Europe, Asia, and Australia for more than two decades. Health advocates and the skincare industry are viewing the decision as a potential turning point for consumer confidence in sun protection products.
The approval comes amid growing public skepticism about sunscreen safety, fueled by concerns over chemical absorption and regulatory delays. By greenlighting a formulation with a long international track record, the FDA signals a willingness to modernize its approval process for over-the-counter sunscreens.
Bemotrizinol offers broad-spectrum protection against UVA and UVB rays, which is considered more effective than some older ingredients. However, the FDA has not yet released specific data on its long-term effects or absorption rates, leaving some questions unanswered for cautious consumers.
Industry groups expect the move to spur innovation and potentially lead to faster approvals of other sunscreen chemicals. For consumers, the change could mean access to products that feel lighter and are more cosmetically elegant, mirroring those already popular abroad.
Some consumer advocates argue that the FDA should have acted sooner, noting that American sunscreens have lagged behind global standards for years. The agency maintains that its rigorous review process ensures safety, even if it is slower.